From: IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy
Number of patients = 17 | |
---|---|
Male/Female | 11/6 |
Median Age at diagnosis yr (range) | 55 (37-78) years |
≤ 65 y = 13 (76.5%), ≥ 65 y = 4 (23.5%) | |
ISS stage at diagnosis | |
I | 7 |
II | 2 |
III | 5 |
Unknown | 3 |
Performance status | |
ECOG < 2 | 9 |
ECOG > 2 | 8 |
Light chain type | |
k | 6 |
λ | 11 |
Bone marrow infiltration | 30% (10-70%) |
Extra osseous disease | 0 |
Bone lesions | 14/17 (82%) |
Median serum monoclonal protein g/dl | 1.05 (0.09-5) |
Median Urine monoclonal protein g/24 h | 0.79 (0-28) |
Urine immunofixation positive | 12/17 (70%) |
Serum β2 microglobulin > 5.5 mg/L | 5/17 (29%) |
Serum albumin < 3.5 g/dl | 5/17 (29%) |
eGFR < 50 ml/min | 8/17 (47%) |
Serum Calcium > 12 mg/dl | 1/17 |
Amyloidosis | 1/17 |
Hemoglobin g/dl, median (range) | 11.9 (6.5-15) |
< 10 | 5/17 (29%) |
WBC count 109/L, median (range) | 6.57 (3.19-16.8) |
> 7 × 109/L | 7/17 (41%) |
Platelet count 109/L, median (range) | 214 (74-518) |
< 100 × 109/L | 1/17 |